Propensity Scores in the Presence of Effect Modification: A Case Study using the Comparison of Mortality on Hemodialysis Versus Peritoneal dialysis by Liem, Ylian S et al.
 
Propensity Scores in the Presence of Effect Modification: A Case
Study using the Comparison of Mortality on Hemodialysis Versus
Peritoneal dialysis
 
 
(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation Liem, Ylian S., John B. Wong, M. G. Myriam Hunink, Frank Th
de Charro, and Wolfgang C. Winkelmayer. 2010. Propensity
scores in the presence of effect modification: A case study using
the comparison of mortality on hemodialysis versus peritoneal
dialysis. Emerging Themes in Epidemiology 7:1.
Published Version doi:10.1186/1742-7622-7-1
Accessed February 19, 2015 12:59:23 AM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:4582570
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-
of-use#LAAEMERGING THEMES
IN EPIDEMIOLOGY
Liem et al. Emerging Themes in Epidemiology 2010, 7:1
http://www.ete-online.com/content/7/1/1
Open Access ANALYTIC PERSPECTIVE
© 2010 Liem et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
Analytic perspective Propensity scores in the presence of effect 
modification: A case study using the comparison of 
mortality on hemodialysis versus peritoneal 
dialysis
Ylian S Liem*1,2, John B Wong3, MG Myriam Hunink1,4, Frank Th de Charro5 and Wolfgang C Winkelmayer6
Abstract
Purpose: To control for confounding bias from non-random treatment assignment in observational data, both 
traditional multivariable models and more recently propensity score approaches have been applied. Our aim was to 
compare a propensity score-stratified model with a traditional multivariable-adjusted model, specifically in estimating 
survival of hemodialysis (HD) versus peritoneal dialysis (PD) patients.
Methods: Using the Dutch End-Stage Renal Disease Registry, we constructed a propensity score, predicting PD 
assignment from age, gender, primary renal disease, center of dialysis, and year of first renal replacement therapy. We 
developed two Cox proportional hazards regression models to estimate survival on PD relative to HD, a propensity 
score-stratified model stratifying on the propensity score and a multivariable-adjusted model, and tested several 
interaction terms in both models.
Results: The propensity score performed well: it showed a reasonable fit, had a good c-statistic, calibrated well and 
balanced the covariates. The main-effects multivariable-adjusted model and the propensity score-stratified univariable 
Cox model resulted in similar relative mortality risk estimates of PD compared with HD (0.99 and 0.97, respectively) with 
fewer significant covariates in the propensity model. After introducing the missing interaction variables for effect 
modification in both models, the mortality risk estimates for both main effects and interactions remained comparable, 
but the propensity score model had nearly as many covariates because of the additional interaction variables.
Conclusion: Although the propensity score performed well, it did not alter the treatment effect in the outcome model 
and lost its advantage of parsimony in the presence of effect modification.
Introduction
Using observational data to compare outcomes associ-
ated with different treatments may result in biased esti-
mates because of non-random treatment assignment. To
correct for variables that may confound an association,
the traditional approach is to apply multivariable-
adjusted modeling, but in recent years, use of propensity
scores has become increasingly popular [1]. The concept
of a multivariate confounder score was first introduced
by Miettinen in 1976 [2], but the formal concept of pro-
pensity scores to estimate causal effects in observational
studies was first described by Rosenbaum and Rubin [3].
A propensity score is a conditional probability of assign-
ment to a particular treatment given a vector of baseline
covariates. Except for unmeasured potential confounding
factors, two patients having the same propensity score
but assigned to different treatments are considered to be
equivalent to a random assignment of treatment. Thus,
adjustment for the propensity score in the outcome
model can balance the observed and included covariates
and remove bias that may arise due to these confounders.
This adjustment can be accomplished by either 1) select-
ing matched pairs of patients each on a different treat-
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ment arm, but with similar propensity scores, 2)
stratifying the sample on the propensity score, calculating
the treatment effect within strata and then pooling the
strata-specific treatment effect estimates, or 3) including
the propensity score itself as a covariate in the outcome
model.
Several advantages of propensity score-stratified versus
traditional multivariable-adjusted modeling have been
suggested. The propensity model does not need to be
parsimonious and easy to understand because it is not the
focus of the study [4]. Furthermore, the propensity score
enables a direct estimation of comparability of the treat-
ment groups by assessing the covariate balance between
groups. Inability to balance confounders alerts investiga-
tors that the treatment groups are not sufficiently over-
lapping with respect to these confounders and that
selection bias may not be resolvable [4]. Traditional mul-
tivariable regression modeling will not detect this
directly.
Patients with end stage renal disease (ESRD) require
renal replacement therapy (RRT). Of all therapeutic
options, renal transplantation is generally associated with
the highest survival and quality of life. However, due to
the shortage of organs, the majority of ESRD patients are
treated with renal dialysis. Two main forms of renal dialy-
sis can be distinguished: hemodialysis (HD) and perito-
neal dialysis (PD). Many factors influence dialysis
treatment assignment: not only the clinical characteris-
tics of a patient, but also patient and physician prefer-
ence, cultural factors and reimbursement policy decisions
may play a role. Therefore, comparison of patient survival
on HD and PD is complicated. Because the one random-
ized controlled trial that has been undertaken to assess
survival differences had to be stopped prematurely
because of low inclusion rates [5], observational studies
have to be relied upon to compare survival on HD versus
PD. Our aim was to compare a propensity score-stratified
model with a traditional multivariable-adjusted model,
specifically in estimating survival of hemodialysis (HD)
versus peritoneal dialysis (PD) patients to assess the pos-
sible advantages of using a propensity score.
Analysis
Methods
Patients
We included all incident patients who started RRT
between January 1st 1987 (start of prospective registra-
tion) and December 31st 2002 from the Dutch End Stage
Renal Disease Registry (RENINE). We excluded patients
younger than 18 years, patients who underwent RRT for
less than 30 days, patients who had more than one epi-
sode of recovery of renal function, or who died directly
following a period of renal recovery, patients who
received a pre-emptive transplantation, patients who died
during the first 90 days of renal replacement therapy and
patients from centers treating fewer than 20 dialysis
patients or fewer than 5 PD patients. The outcome of
interest was all-cause mortality, as registered by RENINE.
The registry collects information on date and cause of
death and verifies its information yearly with all centers
[6,7]. From registry data we also determined age and gen-
der of patients, baseline dialysis modality, year of first
dialysis, and the center at which dialysis was started.
Modality switches among HD, PD, and kidney transplan-
tation over time were also recorded. In the database, pri-
mary renal diagnosis was coded according to the
classification of the European Renal Association-Euro-
pean Dialysis and Transplantation Association (ERA-
EDTA). After examining previously published disease
categories and hazard rates in the Dutch registry, we
aggregated these into five categories: glomerulonephritis
(PRD-GN), hypertension (PRD-HT), renovascular dis-
ease (PRD-RVD), diabetes mellitus (PRD-DM) and a cat-
egory for all other renal diagnoses (PRD-OTH).
Statistical modeling
We adopted an intention-to-treat perspective and, as is
customary in previously published analyses, considered
the dialysis modality on day 91 to be the definite modal-
ity. We left-censored survival time for the first 90 days
and right-censored at first transplantation or December
31st 2002, whichever occurred first. To estimate the inde-
pendent comparison between PD and HD mortality by
controlling for observed potential confounders, we
explored two analytical options: a propensity score-
adjustment approach and the traditional multivariable-
adjustment approach.
The propensity-score approach involved a two-step
approach. First, we predicted PD versus HD treatment
assignment by constructing a logistic regression model
that estimated treatment assignment using all available
variables, as well as age-squared, age-cubed, and all possi-
ble 2-way interactions between the database-variables. As
explained earlier, this model did not need to be parsimo-
nious nor easy to understand, because it was not the
focus of the study. The model calculated the expected
probability or propensity score of each patient being
assigned to PD, accounting for that individual's baseline
characteristics. The propensity score was then evaluated
for the following criteria: 1) a reasonable Nagelkerke's r2-
statistic as a measure of fit and a c-statistic between 0.65
and 0.85 as a measure of discriminative power, 2) good
calibration as measured by the PS-predicted and
observed proportion of PD patients within quintiles of
the propensity score, and 3) balanced covariates within
quintiles of the propensity score [8]. This third criterion
is most important for assessing the appropriateness of the
PS-model [9]. In the second-step, estimating the effect of
treatment assignment on outcome adjusted for the pro-Liem et al. Emerging Themes in Epidemiology 2010, 7:1
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pensity score, we stratified a Cox model containing dialy-
sis modality as the only independent variable on intervals
of 0.01 of the propensity score. Alternative techniques to
adjust for the propensity score include matching or
regression. However , regression is affected by measure-
ment errors in the propensity score [10]. Furthermore, it
assumes a linear relationship between the propensity
score and the natural logarithm of the hazard. Matching
or stratification techniques do not assume such a rela-
tionship, but matching entails exclusion of patients
because of the unavailability of a match. Stratification on
intervals of 0.01 closely resembles matching, but because
the number of patients in either exposure group within a
stratum may vary, only few patients will need to be
excluded. In our analyses, ten strata not containing either
HD or PD patients were excluded.
In the alternative multivariable-adjustment approach,
the calculation of the relative mortality of PD patients
compared with HD patients was conducted by entering
observed characteristics as covariates into the survival
regression model and thereby adjusting for potential con-
founders. The first step in this approach was to estimate
univariable Cox proportional hazards models for all avail-
able variables. Age and year of start of dialysis were
entered into the model as continuous variables and all
other variables as categorical variables. All statistically
significant variables (P < 0.05) from the univariable analy-
ses were introduced into a multivariable main-effects Cox
proportional hazards model. From this multivariable
model, we explored the significance of a quadratic term
(age) and several two-way and three-way interaction
terms. We tested for center effects by entering center as a
categorical variable into the multivariable model. Finally,
we compared the hazard ratios (HR) for mortality with
PD versus HD from the propensity score-stratified and
the multivariable-adjusted models.
Results
Patients
The RENINE Registry prospectively collected data of
20,687 patients who started RRT between January 1st
1987 and December 31st  2002. We discarded 4,044
patients that did not meet inclusion criteria. As a result,
our final sample included 16,643 patients from 47 cen-
ters. Mean age was 59 years (standard deviation, SD: 15.3)
and 58.8% were male. Additional descriptive characteris-
tics are shown in Table 1.
Propensity score analysis
The propensity score model containing age, age2, age3, all
other variables and all possible two-way interactions had
a Nagelkerke's r2 of 0.240 and a c-statistic of 0.752. Leav-
ing all non-significant variables out of the model did not
alter these quality indicators substantially.
The propensity score in quintiles showed good calibra-
tion. The mean propensity scores (the probability of
receiving PD) were 9.1%, 21.4% 32.9%, 46.3% and 64.6%
for each quintile, respectively and were very similar to the
actual proportions of patients on peritoneal dialysis in all
quintiles (see Figure 1). Furthermore, the propensity
score balanced the covariates between the HD and PD
groups except for a slight (1.4 year) difference in age
within the fifth quintile and in the starting year within the
second and the fifth quintile (Table 2). Stratifying the uni-
variable Cox model on 0.01 intervals of the propensity
score yielded no difference in mortality risk between PD
and HD patients (HR = 0.97; 95%CI 0.92-1.02) (Table 3).
Multivariable regression analysis
In the unadjusted Cox model, patients receiving PD had a
30% lower mortality compared with HD patients (HR =
0.70; 95%CI: 0.67-0.74; p < 0.001). The coefficients of all
other univariable models were also statistically significant
(p-values ranging from < 0.001 to 0.02), both in the over-
all population and in the HD and PD groups separately.
The coefficient for the year of starting RRT was not sig-
nificant in the total population, because with increasing
year of start of RRT, the relative risk of dying increased
for HD patients and decreased for PD patients.
In contrast to the univariable model, the multivariable
Cox model, adjusted for main effects of age, gender, pri-
mary renal disease, year of first RRT and treatment center
but without interaction terms revealed that mortality of
PD patients and HD patients did not differ significantly
(Table 3). The HR of PD compared with HD patients was
0.99 (95%CI: 0.94-1.05), which did not differ from the rel-
ative risk estimated by the propensity score-stratified
model (HR 0.97; 95%CI 0.92-1.02). Note however that the
propensity score model involved only one covariate as
opposed to nine in the multivariable Cox model.
Exploration of effect modification
The constructed Cox models did not consider the possi-
bility of effect modifiers on outcome. When tested in the
multivariable model, four interaction variables were sta-
tistically significant: two with modality (age by modality
(HD or PD) and diabetes as the primary cause of renal
disease (PRD-DM) by modality), and two other interac-
tion variables (age by PRD-DM and gender by PRD-DM).
After entering these interaction variables into both the
propensity score-stratified and the multivariable-
adjusted model (Table 4), the hazard ratios of dialysis
modality and all interaction variables with dialysis modal-
ity were statistically significant in both models. As before,
the results from the propensity score-stratified and multi-
variable-adjusted models were essentially identical. The
propensity score-stratified model, however, included
almost the same number of variables as the multivariable-
adjusted model. The only two additional variables in this
multivariable-adjusted model were year of first RRT andLiem et al. Emerging Themes in Epidemiology 2010, 7:1
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dialysis center. Hazard ratios for the combinations of the
interaction variables as estimated by the multivariable-
adjusted model are presented in Table 5. They show a rel-
ative survival benefit of PD compared with HD that
diminishes with increasing age and in the presence of dia-
betes. Since the proportionality assumption was not satis-
fied, time-stratified analyses are presented. The clinical
issues associated with these findings are discussed more
in depth elsewhere [11].
Conclusion and Discussion
In this study of nearly all patients who initiated chronic
dialysis treatment between 1987 and 2002 in The Nether-
lands, we developed a propensity score that fulfilled
accepted quality criteria: it showed a reasonable fit, had a
good c-statistic, calibrated well and balanced the covari-
ates. The Cox model that solely stratified on propensity
score yielded essentially identical effect estimates of PD
ve r sus  HD m ortal it y c om pa r ed wit h t he  m ult ivaria ble -
adjusted model while having the advantage of containing
only one as opposed to nine covariates, thus being more
parsimonious. When excluding interaction terms, dialysis
modality was not an independent predictor of mortality
in either model, but both models were misspecified,
because effect modification was present. After introduc-
ing both interaction terms and all corresponding main
effect variables to account for effect modification, the
propensity score-stratified model contained almost the
same number of covariates as the multivariable-adjusted
model. When the models included interaction variables,
all covariates remained independent predictors, but now
dialysis modality besides its interaction variables became
statistically significant. Supporting our findings, the iden-
tified effect modifiers, age and diabetes as primary renal
disease, correspond to those found in previous studies
[12-15].
Our study informs the discussion of the utility of pro-
pensity score in outcomes research. In theory, the use of
propensity score-stratified modeling may allow for a
more straightforward estimation of the relative mortality
risk in comparison with multivariable-adjusted modeling.
However, our study shows that neglecting effect modifi-
cation in propensity score-stratified models may lead to
erroneous conclusions. Incorporating effect modification
however removes the direct interpretability of the main
treatment effect one wishes to estimate, thereby limiting
one benefit of using a propensity score. Still, Sturmer and
colleagues [16] suggest that the propensity score-adjust-
ment approach may yet have an advantage over tradi-
tional methods when effect modification is present,
because it allows for a summary effect size across all
s t r a t a  o f  t h e  e f f e c t  m o d i f i e r s .  T h i s  c a n  b e  r e l e v a n t  i n
pharmacoepidemiology, to estimate how a total popula-
tion might benefit from a particular drug. However in the
setting of end-stage renal disease, the assignment of a
patient to a specific dialysis modality should be tailored
to a patient's specific pretreatment characteristics and
should not be determined by the summary effect size
across all strata of the effect modifiers.
Table 1: Baseline characteristics of study cohort
All patients HD PD P-value
Number (%) 16,643 10,841 (65.1) 5,802 (34.9)
Age (SD) (yr) 59.0 (15.3) 61.8 (14.6) 53.6 (15.0) <0.001
Female gender (%) 41.2 42.5 38.7 <0.001
Primary renal disease (%) <0.001
GN 13.7 11.1 18.5
HT 11.4 11.7 10.8
RVD 8.7 9.8 6.6
DM 15.2 14.9 16.0
Other 51.0 52.5 48.1
Year of first RRT (%) <0.001
1987-1990 17.0 18.0 14.9
1991-1994 23.5 23.2 24.0
1995-1998 28.6 28.3 29.0
1999-2002 31.0 30.5 32.0
Years of follow-up (SD) 2.38 (2.14) 2.42 (2.24) 2.32 (1.95) 0.007
SD = standard deviation, yr = year, GN = glomerulonephritis, HT = hypertension, RVD = renovascular disease, DM = diabetes mellitus, RRT = 
renal replacement therapy, HD = hemodialysis, PD = peritoneal dialysisLiem et al. Emerging Themes in Epidemiology 2010, 7:1
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Table 2: Baseline characteristics of study cohort, by quintile of propensity score
Quintile 1 2 3 4 5
HD PD p HD PD p HD PD p HD PD p HD PD p
N 3,046 295 2,643 691 2,157 1,127 1,813 1,548 1,182 2,141
(%) (91.2) (8.8) (79.3) (20.7) (65.7) (34.3) (53.9) (46.1) (35.6) (64.4)
Age (yr) 72.5 72.2 0.66 65.0 65.7 0.16 59.0 58.6 0.38 52.7 52.5 0.19 46.6 45.2 0.003
Male gender (%) 49.0 50.2 0.71 58.2 58.5 0.90 62.8 62.6 0.92 61.0 61.0 0.98 63.0 63.1 0.95
Primary renal 
disease (%)
0.27 0.74 0.89 0.37 0.08
GN 7.4 4.4 7.3 6.1 11.1 11.4 12.3 14.5 27.3 31.2
HT 11.2 12.9 12.4 11.7 12.1 11.8 13.0 12.9 8.8 8.2
RVD 13.0 14.2 11.8 12.7 9.6 8.5 6.5 6.3 3.2 2.7
DM 14.0 15.9 14.7 14.5 15.4 16.0 14.3 13.0 17.3 18.6
Other 54.5 52.5 53.8 55.0 51.9 52.4 53.9 53.3 43.3 39.3
Year of first RRT (%) 0.34 0.001 0.40 0.76 0.011
1987-1990 19.4 16.6 19.4 13.0 18.6 16.7 16.7 14.4 12.4 14.8
1991-1994 24.1 27.1 24.3 27.5 24.2 26.3 22.1 25.1 18.0 20.6
1995-1998 28.5 25.8 28.1 30.1 28.0 27.3 27.6 28.5 30.3 30.5
1999-2002 28.0 30.5 28.2 29.4 29.2 29.7 33.6 32.0 39.3 34.1
N = number of patients, yr = year, GN = glomerulonephritis, HT = hypertension, RVD = renovascular disease, DM = diabetes mellitus, RRT = renal 
replacement therapy, HD = hemodialysis, PD = peritoneal dialysis, p = p-value
Other studies that compared propensity score-strati-
fied versus multivariable-adjusted modeling have been
reviewed by Shah and colleagues [4] and Sturmer and
colleagues [1]. Similar to our findings, both studies con-
cluded that propensity score-stratified modeling rarely
led to a different result compared with multivariable-
adjusted modeling. Choosing which method may depend
on the quantity of data. Cepeda and colleagues report
from their simulation study that with eight or more out-
comes per confounder, the multivariable-adjusted logistic
regression model showed better precision [17]. However,
with fewer than eight events per confounder, propensity
score-stratified modeling performed better. Furthermore,
the choice also depends on the research question, as sug-
gested by Kurth and colleagues [18]. They showed that
when there is a non-uniform treatment effect, different
adjustment methods can result in divergent results,
which may all be correct but depend on the research
question implied by the adjustment method. Propensity
score, as opposed to traditional multivariate modeling,
enables a direct estimation of comparability of the treat-
ment groups by assessing the covariate balance between
groups [4].
For the propensity score-adjustment approach, there
are no accepted rules for construction and evaluation of
the propensity score model. Evaluation of a propensity
score model often consists of assessing discrimination
with the c-statistic and calibration with goodness-of-fit
tests. However, Weitzen and colleagues in their simula-
tion study showed that neither the c-statistic nor the Hos-
mer-Lemeshow goodness-of-fit test was sensitive to
omission of an important confounder from the propen-
sity score model [19].
Figure 1 Mean predicted and observed probability of peritoneal 
dialysis assignment per quintile of the propensity score. Predicted 
(%): probability of assignment to peritoneal dialysis as predicted by the 
propensity score; Observed (%): actual prevalence of peritoneal dialysis 
assignment.
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Table 3: Multivariable-adjusted and propensity score-stratified models without interaction variables
Multivariable-adjusted model Propensity score-stratified model
HR (95% CI) HR (95% CI)
Age (per yr) 1.05 (1.05; 1.05) - -
Female vs male gender 0.89 (0.85; 0.93) - -
Primary renal disease vs GN* - -
HT 1.25 (1.13; 1.38) - -
RVD 1.74 (1.57; 1.92) - -
DM 2.24 (2.05; 2.46) - -
Other 1.33 (1.22; 1.44) - -
Year of first RRT (per yr) 0.99 (0.98; 1.00) - -
Dialysis center 0.13 - 1.61# --
Peritoneal vs hemodialysis 0.99 (0.94; 1.05) 0.97 (0.92; 1.03)
* Compared with GN as reference group.
# Range of HRs, we did not provide 95%CIs for center because of the large number of estimates.
yr = year, GN = glomerulonephritis, HT = hypertension, RVD = renovascular disease, DM = diabetes mellitus, RRT = renal replacement therapy, 
HR = hazard ratio
Table 4: Multivariable-adjusted and propensity score-stratified models with interaction variables
Multivariable-adjusted model Propensity score-stratified model
HR (95% CI) HR (95% CI)
Age (per yr) 1.05 (1.04; 1.05) 1.05 (1.04; 1.05)
Female vs male gender 0.87 (0.83; 0.91) 0.87 (0.83; 0.91)
Primary renal disease vs GN* - - - -
HT 1.22 (1.10; 1.35) - -
RVD 1.68 (1.51; 1.85) - -
DM 5.65 (3.95; 8.09) 5.36 (3.73; 7.70)
Other 1.31 (1.21; 1.42) - -
Year of first RRT (per yr) 0.99 (0.99; 1.00) - -
Dialysis center 0.13 - 1.61#† --
Peritoneal vs hemodialysis 0.43 (0.32; 0.57) 0.44 (0.32; 0.60)
Age × Dialysis modality 1.01 (1.01; 1.02) 1.01 (1.01; 1.02)
DM × Dialysis modality 1.22 (1.08; 1.38) 1.23 (1.08; 1.40)
Age × DM 0.98 (0.98; 0.99) 0.98 (0.97; 0.99)
Gender × DM 1.20 (1.07; 1.34) 1.20 (1.07; 1.35)
* Compared with GN as reference group.
# Range of HRs.
† Not presented because of range of HRs.
yr = year, GN = glomerulonephritis, HT = hypertension, RVD = renovascular disease, DM = diabetes mellitus, RRT = renal replacement therapy, 
HR = hazard ratio
Failure to include important confounders can lead to
biased estimates of the treatment effect [20]. Austin and
colleagues reported that propensity scores estimated on
administrative data might not balance all clinical charac-
teristics [21]. This could be particularly relevant to our
study, because the RENINE database is administrative
and does not contain clinical data, in particular co-mor-
bidity data. Information on primary renal diagnosis how-
ever is available with the most important co-morbid
condition, diabetes, likely well-represented because of the
strong correlation between diabetes and diabetes as pri-
mary renal disease (PRD-DM). Further, Weitzen and col-Liem et al. Emerging Themes in Epidemiology 2010, 7:1
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leagues [19] report that omitting a confounder in a
propensity model has little effect on the treatment effect
estimate. This could imply that the propensity score is
f a i r l y  r o b u s t  t o  u n o b s e r v e d  c o n f o u n d e r s  i f ,  a s  a l s o
reported by Rosenbaum [3], at least some of the key vari-
ables that explain treatment assignment are included in
the score. Moreover, omitting a confounder also leads to
biased estimates when using a multivariable-adjusted
model.
To summarize: if propensity score models are con-
structed well and no important confounders are missing,
a treatment effect with a reliable significance level can
usually be estimated, with the advantage of a more parsi-
monious outcome model and the advantage of assessing
covariate balance between treatment groups explicitly.
When the outcome is rare, propensity score-adjustment
yields effect size estimates with a higher precision.
Reviews of studies applying propensity score-adjustment
methods have shown however, that propensity score-
stratified modeling was often not implemented or
reported appropriately [1,4,10]. Researchers should care-
fully assess whether propensity score-adjustment meth-
ods are appropriate for their specific situation.
From our study, we conclude that although the propen-
sity score performed well, it did not alter the treatment
effect in the outcome model and lost its advantage of par-
simony because effect modification was present. Thus,
using a model of mortality of patients on renal replace-
ment therapy as a special case study, our study contrib-
utes to the growing literature supporting the
comparability of traditional multivariable regression and
propensity score methods unless sample size is small and
outcome is rare.
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Table 5: Associations between dialysis modality and mortality for various combinations of the effect modifiers
Hazard ratios of peritoneal dialysis vs. hemodialysis (95% Confidence Intervals)*
>3-6 months# >6-15 months# >15 months#
Age DM
40 No 0.26 (0.17; 0.41) 0.51 (0.39; 0.68) 0.86 (0.74; 1.00)
40 Yes 0.40 (0.23; 0.68) 0.59 (0.44; 0.81) 1.06 (0.88; 1.26)
50 No 0.35 (0.25; 0.48) 0.62 (0.51; 0.76) 0.95 (0.85; 1.05)
50 Yes 0.53 (0.34; 0.83) 0.72 (0.56; 0.93) 1.17 (1.00; 1.35)
60 No 0.46 (0.37; 0.58) 0.75 (0.65; 0.87) 1.05 (0.97; 1.13)
60 Yes 0.71 (0.48; 1.04) 0.87 (0.71; 1.09) 1.29 (1.12; 1.48)
70 No 0.62 (0.50; 0.76) 0.92 (0.80; 1.05) 1.16 (1.07; 1.25)
70 Yes 0.95 (0.64; 1.39) 1.07 (0.85; 1.33) 1.42 (1.23; 1.65)
* From models including age, gender, primary renal disease, year of start of RRT, center and the interaction terms age by modality, diabetes 
by modality, age by diabetes and gender by diabetes.
DM = diabetes as primary renal disease
# Models stratified for time on dialysis, >3-6 months, >6-15 months, and >15 months.Liem et al. Emerging Themes in Epidemiology 2010, 7:1
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